Immune system study for Lyme disease skin condition
Part of Infections clinical trials.
This study looks at how the immune system reacts to the bacteria that cause Lyme disease in people with a skin condition called ACA. It may help doctors understand the disease better and guide future treatments.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be at least 18 years old.
- You must have either: a confirmed diagnosis of chronic atrophic acrodermatitis (ACA) caused by Lyme disease, or be a healthy person with no history of Lyme disease.
- If you have ACA, your antibiotic treatment must be either not started yet or started less than 18 months ago.
- You must not have diabetes, a weakened immune system, or be on immunosuppressive drugs like oral steroids.
- You must not be pregnant or breastfeeding.
- You must not weigh less than 50 kg (about 110 lbs).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial is testing a new blood test to help diagnose Lyme disease (borrelia infection) in children. If you are at the emergency room with symptoms that might be Lyme disease and you have a healthy immune system, you might be able to join.
This study evaluates and treats people who currently have active Lyme disease, as defined by CDC criteria. It aims to provide expert care and follow-up while studying the disease.
This study looks at the health of people who have had Lyme disease, including those with ongoing symptoms after treatment, and those who have recovered or never had it. It aims to understand the disease and find better ways to manage it.
This study looks at how your body's immune system reacts to a tick bite. It may help doctors understand and prevent tick-borne diseases, which are illnesses spread by ticks, like Lyme disease.
This study is for people who have already received four doses of the Lyme vaccine (VLA15) in a previous study. It tests whether a fifth dose is safe and helps the body build more protection against Lyme disease.
This study looks at how Lyme disease during pregnancy might affect a baby's development. It involves questionnaires and possibly an MRI of the baby's brain, done at a visit or remotely.
Hear when a new Lyme Borreliosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.